antifungal treatment – Page 3

COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis—Results of the Prospective MSG-017 Study

mycolabadmin

A fungal infection caused by Aspergillus commonly occurs in COVID-19 patients on ventilators, affecting about 7% of cases. The study found that having this infection was linked to high death rates, but it was unclear whether the fungal infection itself or the severe COVID-19 caused the deaths. Single positive test results for the fungus are not reliable for diagnosis, and antifungal drugs did not improve survival rates.

Prevalence of Tinea pedis in military personnel: a systematic review and meta-analysis

mycolabadmin

Athlete’s foot is a common fungal infection affecting military personnel at rates around 17% globally. Military environments create perfect conditions for this infection through close living quarters, humidity from sweat and boots, and shared facilities. The study found that regions with hot, humid climates have higher infection rates, and proper diagnosis using both microscopy and culture tests is important for accurate detection. Improved hygiene, better-designed footwear, and access to antifungal treatments can significantly reduce infection rates in military settings.

Neurological Sequelae After Paediatric Cryptococcal Meningitis

mycolabadmin

This research reviewed 868 children worldwide who had cryptococcal meningitis, a serious fungal brain infection. One in five surviving children experienced long-term neurological problems, most commonly vision loss, weakness, learning difficulties, or hearing loss. Importantly, no child in the medical literature received proper neurological testing after recovery, meaning the actual burden of problems is likely much higher. The study emphasizes the critical need for formal follow-up assessments and rehabilitation services for these children to help them achieve the best possible outcomes.

Dermatophyte Treatment Failure: A Rapid Global Response to an Emerging Global Health Issue

mycolabadmin

Fungal skin infections affect nearly a billion people worldwide and are becoming increasingly difficult to treat due to growing resistance to common antifungal medications. A new species of fungus called T. indotineae, particularly resistant to the popular antifungal drug terbinafine, is spreading globally from India. To combat this emerging health crisis, doctors and health organizations are working together to create global registries and surveillance programs to track resistant infections and develop better treatment strategies.

Etiological Agents and Predisposing Factors of Superficial Fungal Infections in Northeastern Argentina

mycolabadmin

Researchers studied fungal skin infections in a community in northeastern Argentina, finding that 37% of patients had these infections. The most common cause was a fungus called Trichophyton tonsurans. Poor living conditions like overcrowding and lack of clean water increased infection risk. The study shows that fungal skin infections are a significant health problem in areas with limited access to basic sanitation and water services.

Neonatal Invasive Candidiasis: Current Concepts

mycolabadmin

Serious fungal infections (candidiasis) in newborns have become increasingly difficult to treat, especially in developing countries. The types of fungi causing these infections have changed dramatically, with many now resisting the standard fluconazole treatment. Modern medical care, like proper handwashing, environmental cleaning, and careful line care, is actually more effective at preventing these infections than giving preventive antifungal drugs. Healthcare providers need better tools for quickly identifying which fungal species is causing infection and which drugs will work against it.

New approaches to tackle a rising problem: Large-scale methods to study antifungal resistance

mycolabadmin

Fungal infections are becoming increasingly resistant to antifungal drugs, creating a serious public health challenge. Scientists are using advanced genetic sequencing and laboratory techniques to understand how fungi develop drug resistance and identify the specific genetic changes responsible. By cataloging resistance mutations and creating shared databases, researchers aim to develop better diagnostic tests and treatment strategies to combat these dangerous infections.

Epidemiological profile of dermatophytes at the parasitology-mycology laboratory at Mohammed VI University Hospital in Oujda

mycolabadmin

This study examined fungal skin infections caused by dermatophytes in a Moroccan hospital over four years, analyzing 950 samples. The researchers found that nail infections (onychomycosis) were most common, particularly in people over 50 years old, while scalp infections mainly affected children. The fungus Trichophyton rubrum was responsible for most infections, though Microsporum canis increasingly caused scalp infections, likely due to increased pet ownership in Morocco. The study emphasizes the importance of proper laboratory testing to identify the specific fungus and choose appropriate treatment.

therapeutic action: antifungal treatment